---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-065981"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2025-07-07T23:59:59+00:00"
generated_at: "2026-05-18T09:15:16.254383+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Collegium Pharmaceutical authorizes up to $150M share repurchase program through Dec 2026

## Summary
- Board authorized $150M share repurchase program, valid through Dec 31, 2026.
- Repurchases will be executed on open market based on market conditions and share price.
- Program funded by existing cash on hand; timing and amount of purchases discretionary.

## SEC filing metadata
- accession: 0001104659-25-065981
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2025-07-07T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465925065981/0001104659-25-065981-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465925065981/tm2519449d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-065981
- JSON: https://secwatch.observer/filing/0001104659-25-065981.json
- Plain text: https://secwatch.observer/filing/0001104659-25-065981.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.